David J Straus Selected Research

David J Straus Research Topics

Disease

26	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 04/2003
13	Lymphoma (Lymphomas) 12/2021 - 01/2002
11	Neoplasms (Cancer) 08/2017 - 01/2002
8	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 01/2002
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2021 - 09/2003
6	Hematologic Neoplasms (Hematological Malignancy) 12/2018 - 10/2002
6	Anemia 08/2017 - 10/2002
4	Multiple Myeloma 08/2017 - 10/2002
3	Second Primary Neoplasms (Neoplasms, Second) 01/2022 - 09/2018
3	Febrile Neutropenia 01/2022 - 01/2018
3	Acquired Immunodeficiency Syndrome (AIDS) 10/2016 - 01/2002
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2006 - 10/2002
2	Burkitt Lymphoma (Burkitt's Lymphoma) 12/2021 - 09/2003
2	Neutropenia 10/2021 - 01/2018
2	B-Cell Lymphoma (Lymphoma, B Cell) 08/2017 - 09/2005
2	Leukemia 10/2016 - 05/2011
2	Fatigue 10/2006 - 05/2004
1	Thrombocytopenia (Thrombopenia) 10/2021
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2021
1	Opportunistic Infections (Opportunistic Infection) 01/2020
1	Nausea 08/2017
1	Hypertension (High Blood Pressure) 08/2017
1	Hyperhidrosis 08/2017
1	Sepsis (Septicemia) 11/2012
1	Paraproteinemias (Monoclonal Gammopathy) 04/2011
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 04/2011
1	Necrobiotic Xanthogranuloma 04/2011
1	T-Cell Lymphoma (Lymphoma, T Cell) 11/2007
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 05/2007
1	Infections 03/2005

Drug/Important Bio-Agent (IBA)

11	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2002
8	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022 - 12/2004
8	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 12/2004
8	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 12/2004
7	Brentuximab VedotinIBA 01/2022 - 01/2016
6	Rituximab (Mabthera)FDA Link 12/2021 - 03/2005
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2015 - 01/2002
5	Epoetin Alfa (Epogen)FDA Link 10/2006 - 10/2002
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 10/2016
4	Hemoglobins (Hemoglobin)IBA 10/2006 - 08/2003
3	Bendamustine Hydrochloride FDA Link 01/2020 - 02/2013
3	Etoposide (VP 16)FDA LinkGeneric 03/2015 - 09/2003
3	Prednisone (Sone)FDA LinkGeneric 03/2015 - 01/2002
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2018
2	Gemcitabine FDA Link 10/2021 - 05/2011
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2016 - 08/2006
2	GalliumIBA 08/2006 - 04/2003
2	Darbepoetin alfa (Aranesp)FDA Link 07/2006 - 07/2005
2	epoetin betaIBA 07/2006 - 07/2005
2	Vincristine (Oncovin)FDA LinkGeneric 09/2005 - 01/2002
1	carfilzomibIBA 10/2021
1	Proteasome InhibitorsIBA 10/2021
1	Histone Deacetylase InhibitorsIBA 10/2021
1	romidepsin (FK228)FDA Link 10/2021
1	ElectrolytesIBA 10/2021
1	liposomal doxorubicin (Doxil)FDA Link 10/2021
1	Lenalidomide (CC 5013)FDA Link 10/2021
1	Vinorelbine (Navelbine)FDA LinkGeneric 10/2021
1	pembrolizumabIBA 10/2021
1	ofatumumab FDA Link 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 12/2018
1	Formaldehyde (Formol)FDA Link 12/2018
1	ParaffinIBA 12/2018
1	RNA (Ribonucleic Acid)IBA 12/2018
1	Heme (Haem)IBA 12/2018
1	ibrutinibIBA 01/2018
1	Alkylating AgentsIBA 08/2017
1	veliparibIBA 08/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2017
1	Vorinostat FDA Link 03/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2012
1	Immunoglobulin M (IgM)IBA 04/2011
1	Busulfan (Busulfex)FDA Link 01/2008
1	10-propargyl-10-deazaaminopterin FDA Link 11/2007
1	Reduced Folate Carrier ProteinIBA 11/2007
1	Bexarotene (LGD1069)FDA Link 05/2007
1	Interferon alpha-2 (Roferon-A)FDA Link 05/2007
1	IsotopesIBA 08/2006
1	Proteins (Proteins, Gene)FDA Link 07/2006
1	Interferon-alpha (Interferon Alfa)IBA 07/2006
1	CD20 AntigensIBA 07/2006
1	InterferonsIBA 07/2006
1	Monoclonal AntibodiesIBA 07/2006
1	Ifosfamide FDA LinkGeneric 09/2003

Therapy/Procedure

24	Drug Therapy (Chemotherapy) 10/2021 - 01/2002
18	Therapeutics 01/2022 - 10/2002
7	Radiotherapy 01/2021 - 12/2004
5	Stem Cell Transplantation 01/2018 - 09/2003
3	Combined Modality Therapy 09/2018 - 12/2004
2	Immunotherapy 01/2021 - 01/2021
2	Aftercare (After-Treatment) 10/2019 - 01/2018
2	Highly Active Antiretroviral Therapy (HAART) 09/2003 - 01/2002
1	Transplantation 01/2022
1	Regimen B 10/2021
1	Salvage Therapy 01/2018
1	Combination Drug Therapy (Combination Chemotherapy) 10/2016
1	Palliative Care (Palliative Therapy) 03/2015
1	Bed Rest (Bedrest) 10/2006
1	Erythrocyte Transfusion 07/2006
1	Acupuncture Therapy 05/2004